Three have placebo-controlled trials behind them. Most serums in the ads don’t.
Short answer: for common pattern hair loss, three treatments beat placebo in pooled trials: minoxidil on the scalp, finasteride for men, and laser caps or combs. Everything else in the ads ranges from one small company-run trial to no human trial at all.
“Top 5 hair growth serum” pages rank products and look independent. The one we read labels itself an advertorial, says it was paid by the product it ranks first, and earns a commission on the rest. Its pick lists procyanidin B-2, adenosine and caffeine — each at the concentration of a published trial. That is a real point in its favour, and also exactly how a product can borrow evidence it never earned: none of those trials tested the product.
Hair loss treatments · evidence checked 2026-10-25
Grades are calculated from the studies listed, by fixed rules.
FDA-approved for men (5%) and women (2% and 5% foam). Pooled placebo-controlled trials found it beat placebo in both. Results take months and fade if you stop.
A prescription drug, FDA-approved for men only. Pooled placebo-controlled trials found it beat placebo. It has known side effects — a doctor’s conversation, not an ad’s.
Pooled trials against placebo devices found more hair density after 4–26 weeks, with high variation between trials. This is the red light therapy with the strongest record — but the trials tested particular devices at stated outputs, not any cap.
Hair loss treatments · evidence checked 2026-10-25
Grades are calculated from the studies listed, by fixed rules.
One double-blind trial of 29 men, run by the company that makes the ingredient, in 2001. A related 0.7% apple procyanidin trial by the same group also beat placebo. Neither has been repeated by anyone else in the 20 years since.
Individual trials report thicker hairs, applied twice daily for 6 months — the double-blind one against a niacinamide lotion rather than a placebo. A 2025 review pooling three trials found the changes were not statistically significant.
One open-label trial of 210 men found a 0.2% caffeine liquid "not inferior" to minoxidil 5% on growing-phase hairs. With no placebo group and nobody blinded, it cannot show either worked beyond expectation.
One trial of 100 people: hair counts rose about equally with rosemary oil and minoxidil 2% by 6 months. No placebo group, and the abstract does not say anyone was blinded.
One trial of 32 people: hair counts rose about 8% with the lotion and with minoxidil 3%, with no significant difference. With no placebo group and so few people, it cannot show either beat doing nothing — and the peptide was one of three actives.
We found no controlled trial of copper peptides for hair loss in people (PubMed, searched 2026-10-25) — cell, animal and mechanism studies only.
Its evidence is a 12-week survey of 45 users rating their own hair (89% “noticed” new growth), with no comparison group. Of its six peptides, only acetyl tetrapeptide-3 has a human hair trial, and that was inside a different three-ingredient lotion; GHK-Cu has none (above).
Every reported improvement was in someone with an underlying deficiency or condition. High-dose biotin can also distort some blood tests, including heart and thyroid tests — tell your doctor if you take it.
No trial of the product. Its three actives match concentrations from published trials — 1% procyanidin B-2, 0.75% adenosine, 0.2% caffeine — but those trials tested each ingredient alone and on their own schedules (the double-blind adenosine trial: twice a day), not this combination on the once-a-week routine the ad describes. The comparison page ranking it first says it was paid by the brand.